egnite Health is a B2B diagnostic tool developer that leverages AI-driven algorithms and big data to improve the diagnosis and treatment of cardiovascular diseases. Its flagship product, CardioCare, is a digital platform that helps healthcare providers identify and manage patient conditions such as atrial fibrillation, structural heart disease, heart failure, and coronary artery disease, with the goal of preventing stroke and hospitalizations. The platform aims to improve health outcomes, track patient care journeys, reduce diagnostic variability, and streamline clinical workflows.
With more than 1 million echocardiograms leveraged for its Big Data analytics platform, the company has demonstrated a 55% improvement in workflow efficiencies and a 25% increase in lifesaving therapies for structural heart patients. The company had formed partnerships with 50 hospitals and health systems as of April 2023, and it continues to expand its offerings to include Trial Accelerator Research and Real-World Evidence solutions. Its Trial Accelerator technology utilizes AI to identify eligible patients for clinical trials, while its database of 12 million+ de-identified cardiovascular encounters provides valuable insights for life sciences companies.
Key customers and partnerships
In February 2023 , the company partnered with leading physicians from Morristown’s Gagnon Cardiovascular Institute to enhance the standard of care for individuals with cardiovascular disease.
Funding and Financials
In February 2021 , the firm launched from stealth, originating from the CardioCare platform developed by Edwards Lifesciences, with the goal of leveraging advanced technologies and analytics to improve health outcomes for structural heart-disease patients.
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.